NCT07041125 - Concomitant LAAC/AF Ablation (Watchman FLX Pro) | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

October 30, 2026

Conditions

PFA Ablation and LAAC Procedures

Interventions

DEVICE

Watchman FLX™ Pro device.

Patients eligible for the main DISRUPT-AF Registry with a planned concomitant LAAC procedure using the Watchman FLX™ Pro device.

Trial Locations (11)

15212

RECRUITING

Allegheny General Hospital, Pittsburgh

23225

NOT_YET_RECRUITING

Chippenham Hospital), Richmond

32204

NOT_YET_RECRUITING

Ascension St. Vincent's Jacksonville, Jacksonville

33484

RECRUITING

Arrhythmia Center of South Florida, Delray Beach

35243

RECRUITING

Arrhythmia Institute at Grandview, Birmingham

37203

RECRUITING

HCA Research Institute- Mercy Hospital, Miami

40205

NOT_YET_RECRUITING

Norton Heart & Vascular Institute, Louisville

46184

RECRUITING

Ascension St Vincent -Indianapolis Ascension Health, Indianapolis

52242

RECRUITING

University of Iowa Hospitals and Clinics, Iowa City

78705

RECRUITING

Texas Cardiac Arrhythmia Research Foundation, Austin

84124

RECRUITING

St, Mark's Hospital, Salt Lake City